These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2141682)

  • 1. Bell's palsy: an immune complex disease.
    Larsson A; Jonsson L; Sjöquist J
    ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes and complement components in Bell's palsy.
    Jonsson L; Larsson A; Thomander L
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of circulating immune complexes by chicken anti-human C3 and anti-human C1q microELISA.
    Larsson A; Jonsson L; Sjöquist J
    J Immunol Methods; 1988 Oct; 113(1):93-9. PubMed ID: 3262687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of circulating immune complexes by chicken anti-C4 micro ELISA.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1988 Sep; 27(1):39-43. PubMed ID: 3150766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of complement component C5 to model immune complexes and the use of anti-C5 antibodies for determination of C5-containing circulating immune complexes.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1989 Jan; 28(1):5-9. PubMed ID: 2724329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune complexes and complement in leprosy (author's transl)].
    Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
    Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of complement components C1q, C3, C4 and C5 to a model immune complex in ELISA.
    Larsson A; Sjöquist J
    J Immunol Methods; 1989 Apr; 119(1):103-9. PubMed ID: 2785142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An evaluation of nephelometry and complement-based tests for the detection of circulating immune complexes.
    Izzard L; Van Wyk HA; Potgieter N; Brighton S; Anderson R
    S Afr Med J; 1983 Feb; 63(7):244-6. PubMed ID: 6218628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Occurrence of antigen-antibody complexes in the clinic].
    Tilz GP; Becker H
    Wien Med Wochenschr Suppl; 1990; 107():6-12. PubMed ID: 2147085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of circulating immune complexes quantity detection by three assays--CIF-ELISA, C1q-ELISA and anti-C3 ELISA.
    Stanilova SA; Slavov ES
    J Immunol Methods; 2001 Jul; 253(1-2):13-21. PubMed ID: 11384665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of C3 & C4 levels with filarial immune complexes in bancroftian filariasis.
    Prasad GB; Harinath BC
    Indian J Med Res; 1989 Sep; 89():322-5. PubMed ID: 2697689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
    Santoro F; Bout D; Camus D; Capron A
    Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating immune complexes and complement levels in hemophilic children.
    Verroust F; Adam C; Kourilsky O; Allain JP; Verroust P
    J Clin Lab Immunol; 1981 Sep; 6(2):127-30. PubMed ID: 6912882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes and complement in the course of multiple sclerosis.
    Jans H; Heltberg A; Raun NE
    Acta Neurol Scand; 1982 Oct; 66(4):488-96. PubMed ID: 6216715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
    Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
    Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
    Zwirner J; Dobos G; Götze O
    J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
    Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
    Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.